Phosphate Binders in CKD: ‟New Kids on the Block”
ДОИ:
https://doi.org/10.53778/pjkd31089Клучни зборови:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideАпстракт
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Преземања
Објавено
Издание
Секција
Дозвола
Авторско право(c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Овој труд е лиценциран под Creative Commons Attribution-NonCommercial 4.0 International License.
